Imatinib Completed Phase 2 Trials for Desmoid Tumors / Fibromatosis, Aggressive Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01137916Study to Evaluate Imatinib in Desmoid Tumors